Management of total parenteral nutrition-related superior vena cava obstruction with expandable metal stents

Journal of Parenteral and Enteral Nutrition

Volumn 20, Issue 3, 1996, Pages 222-227

  Hemphill, D J ^a   Sniderman, K W ^a   Allard, J P ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; FEMALE; FIBRINOLYTIC THERAPY; HOME CARE; HUMAN; INTESTINE OBSTRUCTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; SCLERODERMA; STENT; SUPERIOR CAVA VEIN SYNDROME; TOTAL PARENTERAL NUTRITION;

EID: 0029979035     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607196020003222     Document Type: Article

References (33)

1. Torramade JR, Cienfuegos JA, Hernandez J-L, et al: The complications of central venous access systems: a study of 218 patients. Eur J Surg 159:323-327, 1993
2. Fabri PJ, Mirtallo JM, Ruberg RL, et al: Incidence and prevention of thrombosis of the subclavian vein during total parenteral nutrition. Surg Gynecol Obstet 155:238-240, 1982
3. Ladefoged K, Efsen F, Christoffersen JK, et al: Long-term parenteral nutrition 1. Catheter-related complications. Scand J Gastroenterol 16:913-919, 1981
4. Glynn MFX, Langer B, Jeejeebhoy KN: Therapy for thrombotic occlusion of long-term intravenous alimentation catheters. JPEN 4:387-390, 1980
5. Wechler RJ, Spun PW, Conant EF: Thrombosis and infection caused by thoracic venous catheters: pathogenesis and imaging findings. AJR 160:467-471, 1993
6. Mailloux RJ, DeLegge MH, Kirby DF: Pulmonary embolism as a complication of long-term total parenteral nutrition. JPEN 17:578-582, 1993
7. Hill SL, Berry RE: Subclavian vein thrombosis: a continuing challenge. Surgery 108:1-9, 1990
8. Raad II, Luna M, Khalil SM, et al: The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 271:1014-1016, 1994
9. Pithie A, Soutar JS, Pennington CR: Catheter tip position in central vein thrombosis. JPEN 12:613-614, 1988
10. Payzu AN, Eiber HB, Walters S: Studies with cleaving factor V. Proc Soc Exp Biol 125:188-192, 1967
11. Bern MM, Lokich JJ, Wallach SR, et al: Very low doses of warfarin can prevent thrombosis in central venous catheters. Ann Intern Med 112:423-428, 1990
12. Bozzetti F, Scarpa D, Terno G, et al: Subclavian venous thrombosis due to indwelling catheters: a prospective study on 52 patients. JPEN 7:560-562, 1983
13. Di Costanzo JD, Sastre B, Choux R, et al: Mechanism of thrombogenesis during total parenteral nutrition: role of catheter composition. JPEN 12:190-194, 1988
14. Hoar PF, Wilson RM, Mangano DT, et al: Heparin bonding reduces thrombogenicity of pulmonary-artery catheters. N Engl J Med 305:993-995, 1981
15. Mollenholt P, Erikson I, Andersson T: Thrombogenicity of pulmonary-artery catheters. Intensive Care Med 13:57-59, 1987
16. Brismar B, Hardstedt C, Jacobson S, et al: Reduction of catheter-associated thrombosis in parenteral nutrition by intravenous heparin therapy. Arch Surg 117:1196-1199, 1982
17. Ginsberg JS, Kowalchuk G, Hirsh J, et al: Heparin effect on bone density. Thrombos Haemost 64:286-289, 1990
18. Ginsberg JS, Hirsh J: Use of anticoagulants during pregnancy. Chest 95 (Suppl):156S-160S, 1989
19. Cole CW, Bormanis J: Ancrod: a practical alternative to heparin. J Vasc Surg 8:59-63, 1988
20. Deleted in proof
21. Fraschini G, Becker M, Bruso P, et al: Comparative trial of urokinase vs heparin as prophylaxis for central venous ports. Proc Am Soc Clin Oncol 10:337, 1991
22. Lawson M, Bottino JC, Hurtubise MR, et al: The use of urokinase to restore the patency of occluded central venous catheters. Am J Intravenous Ther Clin Nutr 9:29-32, 1982
23. Halery A, Leonov Y, Lewinsohn G, et al: Thrombosis of superior vena cava during total parenteral nutrition, managed successfully with low dose streptokinase. Intensive Care Med 14:72-73, 1988
24. Greenberg S, Kosinski R, Daniels J: Treatment of superior vena cava thrombosis with recombinant tissue type plasminogen activator. Chest 99:1298-1301, 1991
25. Atkinson JB, Bagnall HA, Gomperts E: Investigational use of tissue plasminogen activator (t-PA) for occluded central venous catheters. JPEN 14:310-311, 1990
26. Haire WD, Lieberman RP, Lund GB, et al: Obstructed central venous catheters - restoring function with a 12-hour infusion of low-dose urokinase. Cancer 66:2279-2285, 1990
27. Rosch J, Keller FS, Uchida BT, et al: Interventional management of large venous obstruction. IN Vascular Diseases: Surgical and Interventional Therapy, Strandness DE Jr, van Breda A (eds). Churchill Livingstone, New York, 1994, pp 999-1015
28. Glanz S, Gordon DH, Lipkowitz GS, et al: Axillary and subclavian vein stenosis: percutaneous angioplasty. Radiology 168:371-373, 1988
29. Sherry CS, Diamond NG, Meyers TP, et al: Successful treatment of superior vena cava syndrome by venous angioplasty. AJR 147:834, 1986
30. Dake MD, Semba CP, Wittich GR, et al: Vascular stents for the treatment of superior vena cava obstruction. Radiology 189 (Suppl):114, 1993
31. Lakin PC, Peterson BD, Barton RE, et al: Expandable stents in the treatment of central obstruction in the venous system (Abstr). JVIR 5:1, 1994
32. Rosenblum J, Leef J, Messersmith R, et al: Intravascular stents in the management of acute superior vena cava obstruction of benign etiology. JPEN 18:362-366, 1994
33. Grassi CJ: Inferior vena caval filters: analysis of five currently available devices. AJR 156:813-821, 1991